EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Evaluation of Plant-Derived Virus-like Particles as Intratumoral Immunotherapy Agents

Anete Ogrina-Komarova iD, Zane Kalnina iD, Rebeka Racina iD, Vilija Zeltina, Ramona Petrovska, Ina Balke, Patricija Zaremba, Krista Resne, Juris Jansons iD, Andris Zeltins

Vaccines · 12.08.2026 · 14 (8) · 697

DOI: 10.3390/vaccines14080697 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 12.08.2026. Verfasst von Anete Ogrina-Komarova und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Research and Innovation (NIRI), LV-1006 Riga, Latvia. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Plant-derived virus-like particles (VLPs) are emerging nanoplatforms for local cancer immunotherapy, yet their relative performance across structurally distinct particles remains insufficiently defined.

Methods

We performed a comparative benchmarking study of eleven plant-derived VLPs spanning diverse architectures and functional properties using an integrated workflow of physicochemical characterization, immune-functional profiling, and in vivo evaluation. All VLPs were produced in endotoxin-minimized ClearColi BL21 (DE3), enabling assessment of intrinsic particle-associated immunostimulatory activity with reduced bacterial endotoxin confounding.

Results

In vitro, several VLPs stimulated macrophage-associated responses and enhanced tumor cell killing, although classical M1/M2 polarization markers in RAW264.7 cells did not consistently predict functional cytotoxicity. In a subset of candidates, HEK-TLR3 reporter activity varied substantially under RNA-normalized conditions and was not predicted solely by total RNA content or apparent RNA size distribution. Five candidates were advanced to intratumoral evaluation in the male-derived B16-F10 melanoma model, where CCMV-ss and CMVtt showed trends toward reduced tumor progression and increased immune cell infiltration in male mice. Furthermore, host sex-associated differences in baseline immune features were observed, though these must be interpreted with caution given the H-Y antigen-driven immunogenicity inherent to the male-derived B16-F10 model in female hosts.

Conclusions

This study establishes a standardized comparative framework linking plant VLP properties with immune-functional performance and identifies CCMV-ss and CMVtt as promising candidates for further development as locally administered cancer immunotherapy nanoplatforms.

Schlagwörter

Stichwörter der Autor:innen

in situ vaccinationintratumoral immunotherapymelanomaplant-derived virus-like particles

Autor:innen und Institutionen

  • National Institute of Research and Innovation (NIRI), LV-1006 Riga, Latvia.
  • Faculty of Medicine, Riga Stradins University, Dzirciema 16, LV-1007 Riga, Latvia.

ORCID-Profile: Anete Ogrina-Komarova, Zane Kalnina, Rebeka Racina, Juris Jansons

Förderung

  • European Union

Zitieren

APA

Ogrina-Komarova, A., Kalnina, Z., Racina, R., Zeltina, V., Petrovska, R., Balke, I., Zaremba, P., Resne, K., Jansons, J., & Zeltins, A. (2026). Comparative Evaluation of Plant-Derived Virus-like Particles as Intratumoral Immunotherapy Agents. Vaccines, 14(8), 697. https://doi.org/10.3390/vaccines14080697

Vancouver

Ogrina-Komarova A, Kalnina Z, Racina R, Zeltina V, Petrovska R, Balke I, et al. Comparative Evaluation of Plant-Derived Virus-like Particles as Intratumoral Immunotherapy Agents. Vaccines. 2026;14(8):697. doi:10.3390/vaccines14080697

BibTeX
@article{OgrinaKomarova2026,
  author = {Ogrina-Komarova, Anete and Kalnina, Zane and Racina, Rebeka and Zeltina, Vilija and Petrovska, Ramona and Balke, Ina and Zaremba, Patricija and Resne, Krista and Jansons, Juris and Zeltins, Andris},
  title = {Comparative Evaluation of Plant-Derived Virus-like Particles as Intratumoral Immunotherapy Agents},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {8},
  pages = {697},
  doi = {10.3390/vaccines14080697}
}
Kostenlos starten →